查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1436029

藥品合約包裝：市場佔有率分析、產業趨勢與統計、成長預測（2024-2029）

Pharmaceutical Contract Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計 2024 年藥品合約包裝市場規模為 171.9 億美元，預計到 2029 年將達到 274.5 億美元，預測期內（2024-2029 年）複合年成長率為 9.82%。

藥品合約包裝 - 市場

由於 COVID-19 影響了對管瓶、藥品和其他醫藥產品的需求大幅成長，行業製造商正在爭奪資源並推動加速製造和包裝流程。疫情爆發的頭幾個月，市場上 CMO 和 CPO 的材料都嚴重短缺。這是由於亞太地區面臨供應鏈課題，該地區是藥品和包裝行業原料的主要來源地，導致製造和包裝速度放緩。

主要亮點

  • 由於全球經濟成長、人口成長和老化以及新產品的推出，全球製藥業正在快速成長。根據 IQVIA 的數據，2020 年全球醫藥市場收益為 12,652 億美元，並且正在穩步成長。隨著許多製藥供應商意識到將商業和臨床包裝外包給製藥承包可以增加利潤，該行業的合約包裝正在不斷成長。
  • 過去幾年，美國FDA核准的新藥數量大幅增加。例如，根據食品藥物管理局（藥品評估與研究中心（CDER））的數據，2020年CDER核准的新藥總數為53個，而上一年為48個。此外，學名藥計劃於同年核准或臨時核准了 948 件學名藥申請。 FDA核准的新藥數量不斷增加，對全球藥品合約包裝市場產生正面影響。
  • 此外，預計未來幾年注射劑將比口服等其他給藥途徑獲得市場佔有率。這可能會增加對合約包裝中注射劑解決方案的需求，預計主要製藥供應商將擴大其在這一領域的能力。
  • 例如，2021年1月，諾華對給藥公司Credence MedSystems進行策略性投資。這項投資預計將有助於加速 Credence 藥物輸送系統的開發和擴展，最初將重點放在 Credence Companion 安全注射器系統。
  • 此外，大批量市場對外包裝瓶服務的需求預計將保持穩定。對泡殼包裝和裝瓶服務的需求預計將由維持藥物的需求和高效的新產品上市包裝選項（重點是維持藥物的 30-60-90 天簡報）推動。
  • 此外，歐盟法規要求所有製藥公司在向歐盟供應產品時必須遵守歐盟良好生產規範（GMP）。製造商和進口商必須獲得成員國主管機關的許可和註冊。製造商和進口商定期接受歐盟主管機關或其他核准機構的檢查，以確認符合歐盟 GMP。無論製造商位於何處，此過程均適用。當特定公司進口產品時，進口商有責任確保符合 GMP。歐盟藥品管理法規總結了歐盟藥品管理法規。

藥品合約包裝市場的趨勢

瓶裝藥品包裝可望推動市場成長

  • 將藥品初級包裝到瓶子中需要灌裝瓶子。瓶子灌裝服務在調查市場中佔據很大的市場佔有率，因為一些製藥公司依賴合約包裝公司參與填充程序。
  • 由於重量輕等各種優勢， 寶特瓶填充預計將在預測期內顯著成長，進一步節省空間、運輸和貨運成本。與玻璃瓶填充的藥品不同，塑膠瓶不易破損，這有助於降低玻璃瓶的成本。
  • 擴張活動引人注目，因為合約包裝公司專注於增加裝瓶生產線以提高生產能力，包括將藥品填充到玻璃、金屬和塑膠瓶中的固態劑型以及液體和液體懸浮液。
  • 例如，提供藥品合約包裝服務的組織 Aphena Pharma Solutions 於 2021 年 1 月宣布，利用在固態劑量合約包裝方面的 2,100 萬美元投資，增加了 10 條高速裝瓶線。該公司還計劃在其新收購的 50 萬平方英尺工廠中再安裝 30 條高速生產線，將面向醫藥固體劑量包裝行業的月產能提高到超過 8,000 萬瓶。
  • 此外，對注射藥物的需求不斷成長，極大地推動了製藥業玻璃瓶的成長。腫瘤藥物和其他強效藥物（例如抗體偶聯物、類固醇和需要快速起效的靜脈注射藥物）的強勁市場預計將成為關鍵的成長動力。
  • 此外，糖尿病患者數量的增加是注射藥物玻璃瓶成長的主要動力。根據世界衛生組織 (WHO) 統計，全球約有 4.22 億人患有糖尿病。這種數量的變化將增加對青黴素的需求，這將有助於市場的成長。

北美佔最大市場佔有率

  • 北美藥品合約包裝市場正在迅速增加採用不同的包裝方法，以滿足不斷變化的消費者偏好的期望。日益嚴重的環境問題正在推動製藥業對永續合約包的需求。
  • 除此之外，自動化在藥品合約包裝中的滲透率不斷提高，最大限度地減少了人為處理錯誤，從而推動了該地區的市場成長。除此之外，消費者可支配收入的增加和健康意識的增強正在增加該地區對藥品合約包裝的需求。
  • 許多合約包裝公司已投資擴大其設施和客戶群，並透過收購和合作夥伴關係擴大其地理影響力。 2020年9月，益昇華包裝宣布收購3C！總部位於北卡羅來納州的包裝公司主要為製藥業設計和製造紙箱、文件、標籤和包裝。此類收購使 Essentra Packaging 等公司能夠鞏固其在藥品包裝領域的地位，並為北美和美國藥品製造地提供成長機會。
  • 此外，生技藥品的擴張預計將對區域市場產生重大影響。例如，2021 年 4 月，康泰倫特在印第安納州布魯明頓工廠完成了 1,400 萬美元的擴建，以提高生技藥品的包裝和生產能力。
  • 此外，北美還擁有一些最著名的藥品供應商和包裝解決方案供應商。作為主要成長趨勢之一，該地區的 CPO 正在透過 3PL 服務擴展其服務範圍。
  • 例如，Legacy Pharmaceutical Packaging 於 2020 年 9 月擴大了服務範圍，涵蓋了供應鏈透明度解決方案和涵蓋成藥的 3PL 服務。此外，該公司還將其密蘇裡州聖路易斯總部附近的開放空間設施從 215,000 平方英尺擴大到 500,000 平方英尺。

藥品合約包裝產業概述

由於供應商眾多，全球藥品合約包裝市場的競爭形勢似乎呈現零碎化。擁有大量市場佔有率的領先公司正在不同地區擴大客戶群。此外，許多公司與多家公司進行策略合作，以提高市場佔有率和盈利。市場的最新發展包括：

  • 2021 年 5 月 - UDG Healthcare plc 旗下的合約包裝和臨床供應服務公司Sharp Corporation在賓夕法尼亞州康舍霍肯工廠購買了新土地，作為 1700 萬美元投資的一部分。此次土地購買將使Sharp Corporation能夠在未來增加 cGMP 包裝服務產能，並且是其賓州業務 4,300 萬美元投資的一部分，使該公司的泡殼包裝產能增加 35% 以上。
  • 2020 年 6 月－宣布 PCI Pharma 與契約製造組織和藥品供應服務公司 Experic 簽訂合作夥伴協議，探索臨床和商業製造、包裝和供應鏈服務，推動雙方共同成長。

其他福利

  • Excel 格式的市場預測 (ME) 表
  • 3 個月分析師支持

目錄

第1章簡介

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場洞察

  • 市場概況
  • 產業吸引力－波特五力分析
    • 供應商的議價能力
    • 買方議價能力
    • 新進入者的威脅
    • 競爭公司之間的敵意強度
    • 替代產品的威脅
  • 產業價值鏈分析
  • 評估 COVID-19 對產業的影響

第5章市場動態

  • 市場促進因素
    • 持續努力系列化以支持市場成長
    • 最近對產能擴張以及裝瓶和灌裝服務的投資
  • 市場課題
    • 嚴格的監管要求

第6章市場區隔

  • 依服務類型
    • 一次
      • 瓶子
      • 管瓶
      • 安瓿
      • 泡殼包裝
      • 其他
    • 中學
    • 第三
  • 依地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第7章 競爭形勢

  • 公司簡介
    • Ropack Inc.
    • Sharp（UDG Healthcare）
    • Reed-Lane Inc.
    • PCI Pharma Services
    • UNICEP Packaging LLC
    • Jones Packaging Inc.
    • Almac Group
    • Assemblies Unlimited Inc.
    • AmeriPac
    • MJS Packaging
    • AbbVie Contract Manufacturing
    • Pharma Packaging Solutions
    • Nelipak BV
    • Aphena Pharma Solutions Inc.
    • Southwest Packaging
    • MPH Co-Packing
    • Tjaopak
    • SternMaid GmbH
    • Variopack Lohnfertigungen GmbH
    • CentralPharma
    • Sepha Limited
    • DelobrisPharmaceuticals Limited
    • Wasdell Group
    • DaklaPack Filling
    • LABO Phytophar
    • Tripak Pharmaceuticals
    • Jam Jams
    • AsiapackLimited（Elanders Group）
    • Finishing Services

第8章投資分析

第9章市場的未來

簡介目錄
Product Code: 72168

The Pharmaceutical Contract Packaging Market size is estimated at USD 17.19 billion in 2024, and is expected to reach USD 27.45 billion by 2029, growing at a CAGR of 9.82% during the forecast period (2024-2029).

Pharmaceutical Contract Packaging - Market

With COVID-19 influencing a significant spike in demand for vials, medicines, and other drugs, manufacturers in the industry scrambled their resources and pushed for faster manufacturing and packaging processes. During the initial months of the pandemic, there was a significant shortage of materials for both CMOs and CPOs in the market; owing to supply chain issues faced in the Asia-Pacific region, which commands a prominent position when it comes to pharmaceutical raw materials as well as packaging industry raw materials which resulted in slower manufacturing and packaging.

Key Highlights

  • The global pharmaceutical industry is growing exponentially, driven by global economic growth, a growing and aging population, and new product launches. According to IQVIA, the revenue of the global pharmaceutical market in 2020 stood at USD 1,265.2 billion and growing at a steady pace. As many pharmaceutical vendors recognized that profits could be increased by outsourcing the commercial and clinical packaging to a pharmaceutical contractor, the contract packaging in the industry is expanding.
  • Over the past few years, there's been a significant rise in the number of new drugs approved by the US FDA. For instance, the total number of novel drugs approved by CDER in 2020 stood at 53, which was 48 during the previous year, according to Food and Drug Administration (Center for Drug Evaluation and Research (CDER)). Also, the generic drug program approved or tentatively approved 948 generic drug applications during the year. The increase in the number of new drugs approved by the FDA has positively impacted the global pharmaceutical contract packaging market.
  • Further, injectables are expected to witness increased market share outpacing other routes of administration such as oral over the coming years; owing to this, the demand for injectable solutions is likely to increase in contract packaging, and significant pharmaceutical vendors are expected to expand their capabilities in this space.
  • For instance, in January 2021, Novartis made a strategic investment in drug delivery company Credence MedSystems; the investment is expected to help advance the development and scaling of Credence's drug delivery systems, with an initial focus on the Credence Companion Safety Syringe System.
  • Moreover, the demand for outsourcing bottling services is expected to be stable in the larger volume market. The need for blister packaging and bottling services is expected to be driven by the maintenance drugs and demand for efficient go-to-market packaging options for new products, focusing on 30-60-90 day presentations for maintenance drugs.
  • Further, the EU regulations mandate all pharmaceutical manufacturers to comply with the EU Good Manufacturing Practices (GMP) if they want to supply products to the EU. Then manufacturers and importers must be authorized and registered by a competent authority from a member state. The manufacturers and importers are regularly inspected by an EU competent authority or other approved authority to check the compliance with the EU GMP. This process applies wherever the manufacturer is located. Where a particular company imports products, the importer stands responsible for ensuring compliance with the GMP. The EU legislation governing pharmaceutical products is compiled in "The Rules Governing Medicinal Products in the European Union."

Pharmaceutical Contract Packaging Market Trends

Bottles Pharmaceutical Packaging is Expected to Drive the Market Growth

  • The primary packaging of pharmaceuticals in bottles entails filling the bottles. The bottle filling services hold a significant market share in the studied market as multiple pharmaceutical companies depend on contract packaging companies to partake in the filling procedure.
  • Over the forecast period, plastic bottle filling is expected to significantly grow due to its various advantages, including light-weightedness that further saves space and transportation, and freight charges. Unlike pharmaceuticals filled in glass bottles, plastic bottles are not prone to breakage and help with necessary cost-savings associated with glass bottles.
  • Both solid dosage and Liquid and liquid suspensions filling pharmaceuticals in glass, metal, and plastic bottles are marked with expansion activities as contract packaging companies focus on adding bottling lines to increase production capacity.
  • For instance, Aphena Pharma Solutions, an organization providing pharmaceutical contract packaging services, announced in January 2021 that the company had added ten high-speed bottling lines leveraging its USD 21 million investment in solid dosage contract packaging. The company further intends to install 30 more high-speed lines in its newly acquired 500,000 sq ft facility to increase the monthly capacity to over 80 million bottles to target the pharmaceutical solid dose packaging industry.
  • Moreover, the increasing demand for injectable pharmaceuticals is significantly driving the growth of glass bottles in the pharmaceutical sector. The robust market for oncology and other high-potency drugs (such as antibody conjugates, steroids, and IV fluids that require quick onset of action) is expected to be the key growth driver.
  • Further, the increasing number of people who have diabetes significantly supports the growth of glass bottles for injectable pharmaceuticals. According to the World Health Organization (WHO), around 422 million people have diabetes worldwide. The change in this number increases the demand for penicillin, which is, thereby, contributing to the growth of the market.

North America Accounts for the Largest Market Share

  • The pharmaceutical contract packaging market in North America is rapidly increasing the adoption of different packaging methods to meet the expectations of changing consumer preferences. Rising environmental concerns have stimulated the demand for sustainable contract packaging in the pharmaceutical industry.
  • In addition to this, the rising penetration of automation in pharmaceutical contract packaging has minimized human handling errors, thereby catalyzing market growth in the region. Apart from this, increased disposable incomes and rising consumer health awareness are propelling the demand for pharmaceutical contract packaging in the area.
  • Many contract packaging companies have been investing in expanding their facilities and customer base and enhancing their geographical presence through acquisitions and partnerships. In September 2020, Essentra Packaging announced the purchase of a 3C! Based in North Carolina, Packaging is a designer and manufacturer of cartons, literature, labels, and packaging primarily for the pharmaceutical industry. Such acquisitions allow companies like Essentra Packaging to enhance their position in the pharmaceutical packaging space and provide opportunities to grow in the pharmaceutical manufacturing hub in North America, United States.
  • Further, the expansion of biologics is expected to have a significant impact on the regional market. For example, in April 2021, Catalent completed a USD 14 million expansion for increasing biologics packaging capabilities and capacity at its Bloomington, Indiana facility.
  • Moreover, North America is home to some of the most prominent pharmaceutical vendors and packaging solution providers; among the key growth trends, CPOs in the region extend their service offering with 3PL services.
  • For instance, in September 2020, Legacy Pharmaceutical Packaging expanded its services, including 3PL services, covering supply chain transparency solutions and retail pharma product procurement for over-the-counter medications. In addition to this, the company also expanded its open-space facility near its St Louis, MO, headquarters from 215,000 ft2 to 500,000 ft2.

Pharmaceutical Contract Packaging Industry Overview

The competitive landscape of the global pharmaceutical contract packaging market appears to be fragmented due to the presence of a large number of vendors. The major players with a significant share in the market are expanding their customer base across various regions. In addition, many companies are forming strategic and collaborative initiatives with multiple companies to increase their market share and profitability. Some of the recent developments in the market are:

  • May 2021 - Sharp, a contract packaging, clinical supply services company owned by UDG Healthcare plc, purchased new land as part of a USD 17 million investment in its Conshohocken, PA location. This land purchase will enable Sharp to add future capacity for cGMP packaging services and is part of a broader USD 43 million investment into its Pennsylvania operations, increasing the firm's blister packaging capacity by over 35%.
  • June 2020 - PCI Pharma has announced that it entered into a partnership agreement with Experic, a contract manufacturing organization, and pharmaceutical supply service company, to explore clinical and commercial manufacturing, packaging, and supply chain services driving collective growth for both parties.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHT

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Bargaining Power of Suppliers
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Threat of New Entrants
    • 4.2.4 Intensity of Competitive Rivalry
    • 4.2.5 Threat of Substitute Products
  • 4.3 Industry Value Chain Analysis
  • 4.4 Assessment of Impact of COVID-19 on the industry

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Ongoing efforts towards serialization to aid market growth
    • 5.1.2 Recent capacity expansions & investments in expanding bottling and filling services
  • 5.2 Market Challenges
    • 5.2.1 Stringent Regulatory Requirements

6 MARKET SEGMENTATION

  • 6.1 By Service Type
    • 6.1.1 Primary
      • 6.1.1.1 Bottles
      • 6.1.1.2 Vials
      • 6.1.1.3 Ampoules
      • 6.1.1.4 Blister Packs
      • 6.1.1.5 Others
    • 6.1.2 Secondary
    • 6.1.3 Tertiary
  • 6.2 By Geography
    • 6.2.1 North America
    • 6.2.2 Europe
    • 6.2.3 Asia Pacific
    • 6.2.4 Latin America
    • 6.2.5 Middle East and Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Ropack Inc.
    • 7.1.2 Sharp (UDG Healthcare)
    • 7.1.3 Reed-Lane Inc.
    • 7.1.4 PCI Pharma Services
    • 7.1.5 UNICEP Packaging LLC
    • 7.1.6 Jones Packaging Inc.
    • 7.1.7 Almac Group
    • 7.1.8 Assemblies Unlimited Inc.
    • 7.1.9 AmeriPac
    • 7.1.10 MJS Packaging
    • 7.1.11 AbbVie Contract Manufacturing
    • 7.1.12 Pharma Packaging Solutions
    • 7.1.13 Nelipak BV
    • 7.1.14 Aphena Pharma Solutions Inc.
    • 7.1.15 Southwest Packaging
    • 7.1.16 MPH Co-Packing
    • 7.1.17 Tjaopak
    • 7.1.18 SternMaid GmbH
    • 7.1.19 Variopack Lohnfertigungen GmbH
    • 7.1.20 CentralPharma
    • 7.1.21 Sepha Limited
    • 7.1.22 DelobrisPharmaceuticals Limited
    • 7.1.23 Wasdell Group
    • 7.1.24 DaklaPack Filling
    • 7.1.25 LABO Phytophar
    • 7.1.26 Tripak Pharmaceuticals
    • 7.1.27 Jam Jams
    • 7.1.28 AsiapackLimited (Elanders Group)
    • 7.1.29 Finishing Services

8 INVESTMENT ANALYSIS

9 FUTURE OF THE MARKET